Your browser is no longer supported. Please, upgrade your browser.
PAHC Phibro Animal Health Corporation monthly Stock Chart
PAHC [NASD]
Phibro Animal Health Corporation
Index- P/E18.16 EPS (ttm)1.07 Insider Own0.40% Shs Outstand40.45M Perf Week2.16%
Market Cap778.17M Forward P/E16.08 EPS next Y1.21 Insider Trans0.00% Shs Float20.21M Perf Month13.16%
Income43.30M PEG4.47 EPS next Q0.27 Inst Own- Short Float5.27% Perf Quarter-10.00%
Sales805.80M P/S0.97 EPS this Y-38.20% Inst Trans- Short Ratio7.36 Perf Half Y-23.62%
Book/sh4.76 P/B4.08 EPS next Y5.50% ROA5.50% Target Price20.00 Perf Year-20.47%
Cash/sh2.30 P/C8.46 EPS next 5Y4.06% ROE21.90% 52W Range16.27 - 29.38 Perf YTD-21.75%
Dividend0.48 P/FCF68.26 EPS past 5Y-11.40% ROI8.20% 52W High-33.87% Beta0.47
Dividend %2.47% Quick Ratio1.60 Sales past 5Y1.30% Gross Margin32.70% 52W Low19.42% ATR0.85
Employees1700 Current Ratio2.90 Sales Q/Q2.90% Oper. Margin9.30% RSI (14)58.48 Volatility4.24% 5.14%
OptionableYes Debt/Eq2.07 EPS Q/Q389.20% Profit Margin5.40% Rel Volume0.33 Prev Close19.29
ShortableYes LT Debt/Eq1.97 EarningsNov 04 AMC Payout44.80% Avg Volume144.70K Price19.43
Recom3.20 SMA206.08% SMA507.71% SMA200-12.20% Volume47,865 Change0.73%
Aug-06-20Downgrade Morgan Stanley Equal-Weight → Underweight $20
Feb-06-20Downgrade Gabelli & Co Buy → Hold $30
Jan-28-20Upgrade Barclays Underweight → Equal Weight
Sep-05-19Upgrade Morgan Stanley Underweight → Equal-Weight $21 → $30
Aug-29-19Reiterated BofA/Merrill Underperform $29 → $18
Jun-11-19Initiated Barclays Underweight $25
May-23-19Initiated Guggenheim Neutral
May-09-19Upgrade Gabelli & Co Hold → Buy $42
Aug-23-17Resumed BofA/Merrill Underperform $33
Jun-02-17Downgrade Credit Suisse Outperform → Neutral
Dec-15-16Initiated Piper Jaffray Overweight
Nov-11-16Downgrade Macquarie Neutral → Underperform
Nov-10-16Downgrade Gabelli & Co Buy → Hold
Apr-11-16Reiterated Guggenheim Buy $38 → $34
Feb-04-16Initiated Credit Suisse Outperform
Jan-15-16Downgrade Barclays Overweight → Underweight $36 → $31
Sep-30-15Initiated Gabelli & Co Buy $42
Apr-24-15Reiterated Barclays Overweight $22 → $36
Apr-21-15Downgrade Morgan Stanley Equal-Weight → Underweight
May-06-14Initiated Barclays Overweight $21
Nov-24-20 11:13AM  
Nov-09-20 12:31PM  
Nov-06-20 09:15AM  
Nov-04-20 04:40PM  
Nov-02-20 04:30PM  
Oct-28-20 11:40AM  
Oct-13-20 05:30PM  
Oct-02-20 12:09PM  
Oct-01-20 05:00PM  
Sep-25-20 11:30AM  
Sep-17-20 04:15PM  
Sep-02-20 05:00PM  
Sep-01-20 09:57AM  
Aug-27-20 08:50AM  
07:26AM  
Aug-26-20 04:30PM  
Aug-11-20 01:08PM  
01:07PM  
Aug-03-20 04:00PM  
Jul-27-20 04:15PM  
Jul-17-20 12:28PM  
Jun-27-20 09:56PM  
Jun-03-20 09:58PM  
Jun-02-20 11:33AM  
May-13-20 10:09AM  
May-09-20 11:30AM  
May-07-20 04:40PM  
May-04-20 04:15PM  
Apr-27-20 12:51PM  
Apr-21-20 12:03PM  
Apr-20-20 05:00PM  
Apr-15-20 11:50AM  
09:33AM  
08:57AM  
Apr-09-20 02:00PM  
Apr-08-20 09:12AM  
Apr-07-20 09:30AM  
09:18AM  
Mar-28-20 10:05AM  
Mar-19-20 10:35AM  
Mar-04-20 11:30AM  
Feb-27-20 09:54AM  
Feb-13-20 08:00PM  
Feb-07-20 09:50AM  
Feb-05-20 05:00PM  
11:40AM  
09:14AM  
Feb-04-20 09:16AM  
07:00AM  
Feb-03-20 04:50PM  
04:40PM  
Jan-30-20 09:05AM  
Jan-20-20 11:40AM  
Jan-07-20 12:42PM  
Jan-06-20 05:00PM  
07:53AM  
Dec-12-19 09:02AM  
Dec-10-19 07:47PM  
Dec-09-19 06:44PM  
Dec-04-19 11:30AM  
Nov-19-19 08:56AM  
Nov-06-19 10:43AM  
Nov-04-19 04:50PM  
04:45PM  
Oct-31-19 05:00PM  
Oct-28-19 08:16PM  
Oct-24-19 05:00PM  
12:19PM  
Oct-11-19 12:02PM  
Oct-04-19 11:40AM  
Sep-26-19 09:30AM  
Sep-16-19 11:26AM  
Sep-11-19 12:38AM  
Sep-03-19 11:00AM  
Sep-02-19 11:00PM  
Aug-29-19 06:18AM  
Aug-28-19 11:23PM  
07:17PM  
04:34PM  
08:14AM  
07:39AM  
Aug-27-19 04:52PM  
04:15PM  
Aug-21-19 05:00PM  
Aug-14-19 12:20PM  
Aug-06-19 05:00PM  
Aug-01-19 05:10PM  
Jul-29-19 04:30PM  
Jul-12-19 12:24PM  
Jul-09-19 08:18AM  
Jul-08-19 05:00PM  
Jun-12-19 07:46AM  
Jun-05-19 09:30AM  
May-19-19 10:25PM  
May-14-19 07:42AM  
May-09-19 08:16AM  
May-08-19 12:24AM  
May-06-19 07:38PM  
04:30PM  
04:20PM  
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It also operates in Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.